Search Results for: Arcturus Therapeutics Synthetic Genomics Announce
Articles
November 6, 2017
Arcturus Therapeutics & Synthetic Genomics Announce Strategic Alliance November 6, 2017
Arcturus Therapeutics, Inc. and Synthetic Genomics, Inc. recently announced they have entered into a research collaboration and worldwide license agreement...
August 12, 2020
Arcturus Therapeutics Announces Dosing of its COVID-19 Vaccine Candidate in Phase 1/2 Study August 12, 2020
Arcturus Therapeutics Holdings Inc. recently announced that all subjects in the first cohort have been dosed in the Phase 1/2...
May 5, 2020
Arcturus Therapeutics & Catalent Announce Partnership to Manufacture mRNA-Based COVID-19 Vaccine May 5, 2020
Arcturus Therapeutics Holdings Inc. and Catalent, Inc.recently announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended to….
March 5, 2020
Arcturus Therapeutics & Duke-NUS Medical School Partner to Develop a COVID-19 Vaccine March 5, 2020
Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) recently announced their partnership to develop a Coronavirus….
June 28, 2019
Arcturus Therapeutics Receives Orphan Drug Designation June 28, 2019
Arcturus Therapeutics Holdings Inc. recently announced the US FDA has granted Orphan Drug Designation for the company’s lead product candidate………
